Perspective Therapeutics (CATX) Long-Term Investments (2014 - 2016)

Perspective Therapeutics (CATX) has 3 years of Long-Term Investments data on file, last reported at $3.0 million in Q2 2016.

• For the quarter ending Q2 2016, Long-Term Investments fell 41.78% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2016 stood at $3.0 million (down 41.78% YoY), and the FY2016 full-year result was $3.0 million, down 41.78% from the prior year.
• Long-Term Investments retreated to $3.0 million in Q2 2016, from $5.2 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $5.4 million in Q2 2014 to a low of $3.0 million in Q2 2016.
• A 3-year average of $4.8 million and a median of $5.2 million in 2015 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments dropped 5.45% in 2015 and tumbled 41.78% in 2016, its largest moves.
• Tracing CATX's Long-Term Investments over 3 years: stood at $5.4 million in 2014, then dropped by 4.4% to $5.2 million in 2015, then tumbled by 42.42% to $3.0 million in 2016.
• Business Quant data shows CATX's Long-Term Investments at $3.0 million in Q2 2016, $5.2 million in Q1 2016, and $5.2 million in Q4 2015.